Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
2, 4- DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS
No-Receipt date
2011-01310 - 15/04/2011
No-Filing date
20110400922 - 15/04/2011
No-Granting date
3074779 - 19/04/2011
No-EPO application date
04719989.8 - 12/03/2004
No-EPO granting date
1606265 - 02/02/2011
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
4/2011 - 13/05/2011
Expiration date
13/03/2024
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
GB030592914/03/2003/GB
GB031922715/08/2003/GB
GB032237024/09/2003/GB
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/506
A61K 35/00
A61P 29/00
A61P 37/00
C07D 239/48
C07D 401/12
C07D 401/14
C07D 403/12
C07D 405/12
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
358840
NOVARTIS AG
LICHTSTRASSE 35
4056 BASEL
SWITZERLAND
Inventors
Code
Firstname
Surname
846811
.GARCIA-ECHEVERRIA, CARLOS
846812
KANAZAWA, TAKANORI
846813
KAWAHARA, EIJI
846814
MASUYA, KEIICHI
846815
MATSUURA, NAOKO
846816
MIYAKE, TAKAHIRO
846817
OHMORI, OSAMU
846818
UMEMURA, ICHIRO
Representatives
Code
Firstname
Surname
Address
Town
Zip
1539
ANNA
ROUSSOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4007
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
10/2/2015 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 09/2015 Αρ. Πρωτ. Γ.Δ. 805/2.10.2015
Payments history
11 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).